May 14, 2024 / 08:30PM GMT
Operator
Good day, ladies and gentlemen, and welcome to TRACON Pharmaceuticals first quarter 2024 earnings conference call. At this time, all callers are in a listen only mode. After the speakers' prepared remarks, we will conduct a question and answer session and instructions will be given at that time.
During today's call, we will be making certain forward-looking statements, including statements regarding expected timing of clinical trials and results, regulatory activities, plans for future clinical trials, financing opportunities, our development plans and strategies, potential cost savings and other benefits deliverable through our product development platform or PDP, ability to enter into additional licensing agreements, ability to generate non-dilutive capital using the PDP, market size estimates, and whether the company's stock will remain listed on NASDAQ.
These statements are subject to various risks that are described in our filings made with the Securities Exchange Commission, including our Annual Report on Form 10-K for the year ended December 31, 2023 and subsequent Quarterly
Q1 2024 TRACON Pharmaceuticals Inc Earnings Call Transcript
May 15, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers